A Nordic initiative for a more personal and accurate diagnostic pathway for prostate cancer
Scand J Prim Health Care
.
2020 Sep;38(3):249-250.
doi: 10.1080/02813432.2020.1801148.
Authors
Svein R Kjosavik
1
2
,
Karina Dalsgaard Sørensen
3
4
,
Kristina Hotakainen
5
6
,
Henrik Grönberg
7
8
Affiliations
1
The General Practice and Care Coordination Research Group, Stavanger University Hospital, Stavanger, Norway.
2
Faculty of Health Sciences, University of Stavanger, Stavanger, Norway.
3
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
4
Department of Molecular Medicine, Aarhus University Hospital, Aarhus, Denmark.
5
Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
6
Mehiläinen Oy Laboratory, Helsinki, Finland.
7
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
8
Department of Oncology, Capio S:t Görans Hospital, Stockholm, Sweden.
PMID:
32791937
PMCID:
PMC7470020
DOI:
10.1080/02813432.2020.1801148
No abstract available
Publication types
Editorial
MeSH terms
Artificial Intelligence
Biopsy
Humans
Male
Prostatic Neoplasms / diagnosis*
Scandinavian and Nordic Countries